Subpart C—Index of Legally Marketed Unapproved New Animal Drugs for Minor Species
Sections
Section numbering in the official eCFR can be non-consecutive. Omitted section numbers are not treated here as reserved unless the source explicitly labels them that way.
-
516.111
§ 516.111 Scope of this subpart. -
516.115
§ 516.115 Definitions. -
516.117
§ 516.117 Submission of correspondence under this subpart. -
516.119
§ 516.119 Permanent-resident U.S. agent for foreign requestors and holders. -
516.121
§ 516.121 Meetings. -
516.123
§ 516.123 Informal conferences regarding agency administrative actions. -
516.125
§ 516.125 Investigational use of minor species new animal drugs to support indexing. -
516.129
§ 516.129 Content and format of a request for determination of eligibility for indexing. -
516.131
§ 516.131 Refuse to file a request for determination of eligibility for indexing. -
516.133
§ 516.133 Denying a request for determination of eligibility for indexing. -
516.135
§ 516.135 Granting a request for determination of eligibility for indexing. -
516.137
§ 516.137 Notification of decision regarding eligibility for indexing. -
516.141
§ 516.141 Qualified expert panels. -
516.143
§ 516.143 Written report. -
516.145
§ 516.145 Content and format of a request for addition to the index. -
516.147
§ 516.147 Refuse to file a request for addition to the index. -
516.149
§ 516.149 Denying a request for addition to the index. -
516.151
§ 516.151 Granting a request for addition to the index. -
516.153
§ 516.153 Notification of decision regarding index listing. -
516.155
§ 516.155 Labeling of indexed drugs. -
516.157
§ 516.157 Publication of the index and content of an index listing. -
516.161
§ 516.161 Modifications to indexed drugs. -
516.163
§ 516.163 Change in ownership of an index file. -
516.165
§ 516.165 Records and reports. -
516.167
§ 516.167 Removal from the index. -
516.171
§ 516.171 Confidentiality of data and information in an index file.